Pharmacokinetic boosting of olaparib: An open-label, prospective, cross-over study

被引:0
|
作者
Overbeek, J. [1 ]
Guchelaar, N. [2 ]
Ali, M. I. Mohmaed [3 ,4 ]
Ottevanger, P. B.
Bloemendal, H. [5 ]
Koolen, S. [2 ]
Mathijssen, R. [2 ]
Boere, I. [6 ]
Hamberg, P. [6 ,7 ]
Huitema, A. [3 ,4 ]
Sonke, G. [8 ,9 ]
Opdam, F. [8 ,9 ]
Ter Heine, R. [1 ]
Van Erp, N. [1 ]
机构
[1] Radboud Univ Nijmegen, Pharm, Med Ctr, Nijmegen, Netherlands
[2] Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands
[3] Netherlands Canc Inst, Dept Pharm & Pharmacol, Amsterdam, Netherlands
[4] Antoni Leeuwenhoek, Amsterdam, Netherlands
[5] Radboud Univ Nijmegen, Med Oncol Dept, Med Ctr, Nijmegen, Netherlands
[6] Erasmus Univ, Dept Med Oncol, Med Ctr, Rotterdam, Netherlands
[7] Franciscus Gasthuis & Vlietland, Med Oncol, Schiedam, Netherlands
[8] NKI Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[9] AVL Antoni Leeu wenhoek Hosp, Amsterdam, Netherlands
关键词
D O I
10.1016/j.annonc.2023.09.1948
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
769P
引用
收藏
页码:S522 / S522
页数:1
相关论文
共 50 条
  • [1] Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study)
    Overbeek, Joanneke K.
    Guchelaar, Niels A. D.
    Ali, Ma Ida Mohmaed
    Ottevanger, Petronella B.
    Bloemendal, Haiko J.
    Koolen, Stijn L. W.
    Mathijssen, Ron H. J.
    Boere, Ingrid A.
    Hamberg, Paul
    Huitema, Alwin D. R.
    Sonke, Gabe S.
    Opdam, Frans L.
    ter Heine, Rob
    van Erp, Nielka P.
    EUROPEAN JOURNAL OF CANCER, 2023, 194
  • [2] Impact of dehydration on laparoscopic performance: a prospective, open-label, randomized cross-over trial
    Bereuter, Jean-Paul
    Geissler, Mark Enrik
    Geissler, Rona
    Schmidt, Sofia
    Buck, Nathalie
    Weiss, Juliane
    Krause-Juettler, Grit
    Weitz, Juergen
    Distler, Marius
    von Bechtolsheim, Felix
    Oehme, Florian
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2023, 38 (3): : 1390 - 1397
  • [3] Impact of dehydration on laparoscopic performance: a prospective, open-label, randomized cross-over trial
    Jean-Paul Bereuter
    Mark Enrik Geissler
    Rona Geissler
    Sofia Schmidt
    Nathalie Buck
    Juliane Weiß
    Grit Krause-Jüttler
    Jürgen Weitz
    Marius Distler
    Felix von Bechtolsheim
    Florian Oehme
    Surgical Endoscopy, 2024, 38 : 1390 - 1397
  • [4] VEgetaRian Diet in patients with Ischemic heart disease (VERDI): an open-label, randomized, prospective, cross-over study
    Djekic, D.
    Carlsson, F.
    Landberg, R.
    Sarnqvist, C.
    Cao, Y.
    Tremaroli, V.
    Backhed, F.
    Frobert, O.
    EUROPEAN HEART JOURNAL, 2019, 40 : 3819 - 3819
  • [5] RANDOMIZED, OPEN-LABEL CROSS-OVER STUDIES TO ASSESS THE POTENTIAL PHARMACOKINETIC INTERACTION OF WARFARIN OR DIGOXIN AND SEVELAMER CARBONATE
    Ruff, Dennis
    Heaton, Jeremy
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A66 - A66
  • [6] Acceptability of Prednisolone in an Open-Label Randomised Cross-Over Study-Focus on Formulation in Children
    Haslund-Krog, Sissel Sundell
    Jorgensen, Inger Merete
    Dalhoff, Kim
    Holst, Helle
    CHILDREN-BASEL, 2022, 9 (08):
  • [7] Effects of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective open-label cross-over drug-interaction study
    van der Bol, J. M.
    Verweij, J.
    de Jong, F. A.
    Loos, W. J.
    Lam, M. H.
    van Meerten, E.
    Mathijssen, R. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Truncated AUC in the evaluation of fluconazole bioequivalence -: A cross-over, randomised, open-label study in healthy volunteers
    Portolés, A
    Almeida, S
    Terleira, A
    de Pablo, I
    Filipe, A
    Caturla, MC
    Moreno, A
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2004, 54 (11): : 752 - 756
  • [9] An open-label,randomized,cross-over bioequivalence study of lafutidine 10 mg under fasting condition
    Bhupesh Dewan
    Raghuram Chimata
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2010, 1 (05) : 112 - 118
  • [10] Pharmacokinetic interaction of glycopyrronium bromide pMDI and formoterol pMDI: A randomized, open-label, single-dose, 4-way cross-over study
    Mariotti, Fabrizia
    Collarini, Sara
    Compagnoni, Anna
    Cuomo, Dario
    Muraro, Annamaria
    Acerbi, Daniela
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46